Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative)

v3.20.2
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jul. 28, 2020
Jul. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Aug. 06, 2020
Nov. 30, 2019
Nov. 30, 2018
Gross proceeds from sale of stock     $ 90,003,980 $ 40,596,961      
April 2020 Sale Agreement [Member]              
Aggregate common stock sold, shares     8,113,794        
Gross proceeds from sale of stock     $ 43,702,000        
Stock subscriptions receivable     $ 16,676,000        
April 2020 Sale Agreement [Member] | Subsequent Event [Member]              
Aggregate common stock sold, shares   1,053,286          
Gross proceeds from sale of stock   $ 8,148,000          
Loan Agreement [Member]              
Interest rate           5.25% 3.07%
Loan Agreement [Member] | Subsequent Event [Member] | K2 HealthVentures LLC [Member]              
Secured debt $ 50,000,000            
Debt maturity date Aug. 01, 2024            
Interest rate 8.50%            
Debt conversion per share $ 9.40            
Debt description The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the "Prime Rate" plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.            
Warrants to purchase shares of common stock, exercised 86,206            
Exercise price of warrants $ 6.96            
Loan Agreement [Member] | Subsequent Event [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]              
Debt conversion amount $ 5,000,000            
Loan Agreement [Member] | Subsequent Event [Member] | K2 HealthVentures LLC [Member] | Prime Rate [Member]              
Interest rate 5.25%            
Loan Agreement [Member] | Subsequent Event [Member] | K2 HealthVentures LLC [Member] | First Tranche [Member]              
Secured debt $ 20,000,000            
Loan Agreement [Member] | Subsequent Event [Member] | K2 HealthVentures LLC [Member] | Second Tranche [Member]              
Secured debt 20,000,000            
Loan Agreement [Member] | Subsequent Event [Member] | K2 HealthVentures LLC [Member] | Third Tranche [Member]              
Secured debt $ 10,000,000            
August 2020 Sale Agreement [Member] | Subsequent Event [Member] | Jefferies LLC [Member]              
Commission percentage         3.00%    
Authorized to offer and sell up of common stock         $ 150,000,000